490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Market cap: $499.6M (2/09/2026)
Price: $2.99
Investor Presentation
Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
Neumora Therapeutics Converts $2.5 Million Term Loan to Common Stock
Reports Third Quarter 2025 Financial Results and Provides Business Update
Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
Earnings Release
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement